Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedetta Belloni

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|April 10, 2012
Recent advances in the management of cutaneous lymphomasBenedetta Belloni, Naomi Johansen, L Frank Glass, et al.
Current Opinion in Allergy and Clinical Immunology|September 5, 2008
Novel immunological approaches in the treatment of atopic eczemaBenedetta Belloni, Christian Andres, Markus Ollert, et al.
Chemical Immunology and Allergy|May 23, 2012
Cutaneous drug eruptions associated with the use of new oncological drugsBenedetta Belloni, Nicola Schönewolf, Sima Rozati, et al.
Pediatric Dermatology|November 16, 2011
Atypical diaper dermatitis: contact allergy to mercapto compoundsAnna Theresa Onken, Julia Baumstark, Benedetta Belloni, et al.
Journal of Cutaneous Pathology|July 21, 2009
Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumorsChristian Andres, Benedetta Belloni, Ursula Puchta, et al.
Journal of Clinical Pathology|November 6, 2012
Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative systemBenedetta Belloni, Chiara Lambertini, Paolo Nuciforo, et al.
Experimental Dermatology|June 9, 2011
Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesionsKatharina Frey, Michael Fiechter, Kathrin Schwager, et al.
European Journal of Dermatology : EJD|April 12, 2014
Clinical implications of distinct metastasizing preferences of different melanoma subtypesNicola L Schoenewolf, Benedetta Belloni, Mathew Simcock, et al.
Plos One|March 22, 2013
RASopathic skin eruptions during vemurafenib therapyJeannine D Rinderknecht, Simone M Goldinger, Sima Rozati, et al.
Plos One|September 22, 2011
Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanomaMarkus Essler, Anna Link, Benedetta Belloni, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|April 10, 2012
Recent advances in the management of cutaneous lymphomasBenedetta Belloni, Naomi Johansen, L Frank Glass, et al.
Current Opinion in Allergy and Clinical Immunology|September 5, 2008
Novel immunological approaches in the treatment of atopic eczemaBenedetta Belloni, Christian Andres, Markus Ollert, et al.
Chemical Immunology and Allergy|May 23, 2012
Cutaneous drug eruptions associated with the use of new oncological drugsBenedetta Belloni, Nicola Schönewolf, Sima Rozati, et al.
Pediatric Dermatology|November 16, 2011
Atypical diaper dermatitis: contact allergy to mercapto compoundsAnna Theresa Onken, Julia Baumstark, Benedetta Belloni, et al.
Journal of Cutaneous Pathology|July 21, 2009
Prevalence of MCPyV in Merkel cell carcinoma and non-MCC tumorsChristian Andres, Benedetta Belloni, Ursula Puchta, et al.
Journal of Clinical Pathology|November 6, 2012
Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative systemBenedetta Belloni, Chiara Lambertini, Paolo Nuciforo, et al.
Experimental Dermatology|June 9, 2011
Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesionsKatharina Frey, Michael Fiechter, Kathrin Schwager, et al.
European Journal of Dermatology : EJD|April 12, 2014
Clinical implications of distinct metastasizing preferences of different melanoma subtypesNicola L Schoenewolf, Benedetta Belloni, Mathew Simcock, et al.
Plos One|March 22, 2013
RASopathic skin eruptions during vemurafenib therapyJeannine D Rinderknecht, Simone M Goldinger, Sima Rozati, et al.
Plos One|September 22, 2011
Prognostic value of [18F]-fluoro-deoxy-glucose PET/CT, S100 or MIA for assessment of cancer-associated mortality in patients with high risk melanomaMarkus Essler, Anna Link, Benedetta Belloni, et al.
Pageof 2